SCHEMBL20058786

SCHEMBL20058786

CC(O)n1cc(F)c2c(N)ncnc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CB P42338 10/20 0.43
PIK3CG P48736 10/20 0.43
PRKDC P78527 10/20 0.43
PIK3CD O00329 9/20 0.43
PIK3CA P42336 9/20 0.43
KDR P35968 13/20 0.42
SRC P12931 12/20 0.42
PI4KB Q9UBF8 9/20 0.42
ABL1 P00519 9/20 0.42
EGFR P00533 9/20 0.42
HCK P08631 9/20 0.42
MTOR P42345 9/20 0.42
EPHB4 P54760 9/20 0.42
PRMT5 O14744 1/20 0.41
WDR77 Q9BQA1 1/20 0.41
ADORA2A P29274 2/20 0.41
ADORA1 P30542 2/20 0.41
ADORA2B P29275 1/20 0.41
PI4KA P42356 1/20 0.41
PI4K2B Q8TCG2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6364419 0.87 PIK3CD (0.51) PIK3CBPIK3CGPRKDCPIK3CDPIK3CA
SCHEMBL22381516 0.86 PI4KB (0.41) PIK3CBPIK3CGPRKDCPIK3CDPIK3CA
SCHEMBL21758960 0.82 ADORA2A (0.55) PIK3CBPIK3CGPRKDCPIK3CDPIK3CA
SCHEMBL19187882 0.78 KDR (0.40) PIK3CBPIK3CGPRKDCPIK3CDPIK3CA
SCHEMBL19402563 0.77 AHCY (0.39) PIK3CBPIK3CGPRKDCPIK3CDPIK3CA
SCHEMBL12966924 0.76 RET (0.39) PIK3CBPIK3CGPRKDCPIK3CDPIK3CA
SCHEMBL29324056 0.76 KDR (0.39) PIK3CBPIK3CGPRKDCPIK3CDPIK3CA
SCHEMBL14816754 0.76 RET (0.39) PIK3CBPIK3CGPRKDCPIK3CDPIK3CA
SCHEMBL24222133 0.76 SRC (0.38) PIK3CBPIK3CGPRKDCPIK3CDPIK3CA
SCHEMBL6430725 0.75 EIF2AK3 (0.46) PI4KBADORA2AADORA1PI4KAPI4K2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2906579-B1 2'-CHLORO NUCLEOSIDE ANALOGS FOR HCV INFECTION IDENIX PHARMACEUTICALS LLC (US) 2018-04-18 EP disclosed